サマリー

米国のゲノム市場 2023-2027
米国のゲノミクス市場は、2022年から2027年にかけて52億8,467万米ドルの成長が予測され、予測期間中のCAGRは10.45%で加速すると予測されています。当レポートでは、米国のゲノミクス市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、遺伝子配列決定のコスト削減、ゲノムデータベースの作成とアップグレードに対する需要の増加、個別化医療に対する需要の高まりによって牽引されています。
Technavio社の米国ゲノミクス市場は以下のように分類されます：
用途別
- 診断
- 創薬
- その他
エンドユーザー別
- 病院・クリニック
- 学術・研究機関
- 製薬・バイオテクノロジー企業
- その他
ソリューション別
- 製品別
- サービス別
本調査では、今後数年間における米国のゲノミクス市場の成長を牽引する主な要因の一つとして、単一細胞ベースのゲノミクス解析の採用が拡大していることを挙げている。また、シークエンシング技術の進歩や腫瘍学におけるゲノミクスの応用拡大が、市場の大きな需要につながるとしている。
この調査レポートは、米国のゲノミクス市場を調査・分析し、以下の刊行物を収録しています：
- 米国のゲノミクス市場規模
- 米国のゲノミクス市場予測
- 米国のゲノミクス市場産業分析
本レポートでは、米国におけるゲノミクス市場をリードするベンダー（Agilent Technologies Inc.、BGI Genomics Co.Ltd.、Bio Rad Laboratories Inc.、Caris Life Sciences、CENTOGENE NV、Color Health Inc.、Danaher Corp.、Eurofins Scientific SE、F. Hoffmann La Roche Ltd.、Illumina Inc.、Invitae Corp.、LetsGetChecked、Myriad Genetics Inc.、Oxford Nanopore Technologies plc、Pacific Biosciences of California Inc.、PerkinElmer Inc.、Personalis Inc.、QIAGEN NV、Thermo Fisher Scientific Inc.、Twist Bioscience Corp.などです。また、米国のゲノム市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/us-genomics-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Country Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Solution
o Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 08: Parent market
o Exhibit 09: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 10: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 11: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 12: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 13: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 14: Chart on US: Year-over-year growth 2022-2027 (%)
o Exhibit 15: Data Table on US: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Genomics market in US 2017 - 2021
o Exhibit 16: Historic Market Size - Data Table on genomics market in US 2017 - 2021 ($ million)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 17: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 18: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Solution Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Solution Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 20: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 23: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 24: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 25: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 26: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 27: Chart on Application - Market share 2022-2027 (%)
o Exhibit 28: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 29: Chart on Comparison by Application
o Exhibit 30: Data Table on Comparison by Application
o 6.3 Diagnostic - Market size and forecast 2022-2027
o Exhibit 31: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
o Exhibit 32: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
o Exhibit 33: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
o Exhibit 34: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
o 6.4 Drug discovery - Market size and forecast 2022-2027
o Exhibit 35: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million)
o Exhibit 37: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
o Exhibit 38: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 39: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 41: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 42: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Application
o Exhibit 43: Market opportunity by Application ($ million)
o Exhibit 44: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 45: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 46: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 47: Chart on Comparison by End-user
o Exhibit 48: Data Table on Comparison by End-user
o 7.3 Hospitals and clinics - Market size and forecast 2022-2027
o Exhibit 49: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
o Exhibit 52: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
o 7.4 Academic and research institutes - Market size and forecast 2022-2027
o Exhibit 53: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
o Exhibit 55: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
o Exhibit 56: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
o 7.5 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
o Exhibit 57: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 59: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
o Exhibit 60: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 61: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by End-user
o Exhibit 65: Market opportunity by End-user ($ million)
o Exhibit 66: Data Table on Market opportunity by End-user ($ million)
• 8 Market Segmentation by Solution
o 8.1 Market segments
o Exhibit 67: Chart on Solution - Market share 2022-2027 (%)
o Exhibit 68: Data Table on Solution - Market share 2022-2027 (%)
o 8.2 Comparison by Solution
o Exhibit 69: Chart on Comparison by Solution
o Exhibit 70: Data Table on Comparison by Solution
o 8.3 Products - Market size and forecast 2022-2027
o Exhibit 71: Chart on Products - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Products - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Products - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Products - Year-over-year growth 2022-2027 (%)
o 8.4 Services - Market size and forecast 2022-2027
o Exhibit 75: Chart on Services - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Services - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Services - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Services - Year-over-year growth 2022-2027 (%)
o 8.5 Market opportunity by Solution
o Exhibit 79: Market opportunity by Solution ($ million)
o Exhibit 80: Data Table on Market opportunity by Solution ($ million)
• 9 Customer Landscape
o 9.1 Customer landscape overview
o Exhibit 81: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 82: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 83: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 84: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 85: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 86: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 87: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 88: Agilent Technologies Inc. - Overview
o Exhibit 89: Agilent Technologies Inc. - Business segments
o Exhibit 90: Agilent Technologies Inc. - Key offerings
o Exhibit 91: Agilent Technologies Inc. - Segment focus
o 12.4 BGI Genomics Co. Ltd.
o Exhibit 92: BGI Genomics Co. Ltd. - Overview
o Exhibit 93: BGI Genomics Co. Ltd. - Product / Service
o Exhibit 94: BGI Genomics Co. Ltd. - Key offerings
o 12.5 Bio Rad Laboratories Inc.
o Exhibit 95: Bio Rad Laboratories Inc. - Overview
o Exhibit 96: Bio Rad Laboratories Inc. - Business segments
o Exhibit 97: Bio Rad Laboratories Inc. - Key news
o Exhibit 98: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 99: Bio Rad Laboratories Inc. - Segment focus
o 12.6 Color Health Inc.
o Exhibit 100: Color Health Inc. - Overview
o Exhibit 101: Color Health Inc. - Product / Service
o Exhibit 102: Color Health Inc. - Key offerings
o 12.7 Danaher Corp.
o Exhibit 103: Danaher Corp. - Overview
o Exhibit 104: Danaher Corp. - Business segments
o Exhibit 105: Danaher Corp. - Key news
o Exhibit 106: Danaher Corp. - Key offerings
o Exhibit 107: Danaher Corp. - Segment focus
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 108: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 109: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 110: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 111: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 112: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 Illumina Inc.
o Exhibit 113: Illumina Inc. - Overview
o Exhibit 114: Illumina Inc. - Business segments
o Exhibit 115: Illumina Inc. - Key news
o Exhibit 116: Illumina Inc. - Key offerings
o Exhibit 117: Illumina Inc. - Segment focus
o 12.10 LetsGetChecked
o Exhibit 118: LetsGetChecked - Overview
o Exhibit 119: LetsGetChecked - Product / Service
o Exhibit 120: LetsGetChecked - Key offerings
o 12.11 Myriad Genetics Inc.
o Exhibit 121: Myriad Genetics Inc. - Overview
o Exhibit 122: Myriad Genetics Inc. - Product / Service
o Exhibit 123: Myriad Genetics Inc. - Key offerings
o 12.12 Oxford Nanopore Technologies plc
o Exhibit 124: Oxford Nanopore Technologies plc - Overview
o Exhibit 125: Oxford Nanopore Technologies plc - Product / Service
o Exhibit 126: Oxford Nanopore Technologies plc - Key offerings
o 12.13 Pacific Biosciences of California Inc.
o Exhibit 127: Pacific Biosciences of California Inc. - Overview
o Exhibit 128: Pacific Biosciences of California Inc. - Product / Service
o Exhibit 129: Pacific Biosciences of California Inc. - Key offerings
o 12.14 PerkinElmer Inc.
o Exhibit 130: PerkinElmer Inc. - Overview
o Exhibit 131: PerkinElmer Inc. - Business segments
o Exhibit 132: PerkinElmer Inc. - Key news
o Exhibit 133: PerkinElmer Inc. - Key offerings
o Exhibit 134: PerkinElmer Inc. - Segment focus
o 12.15 QIAGEN NV
o Exhibit 135: QIAGEN NV - Overview
o Exhibit 136: QIAGEN NV - Product / Service
o Exhibit 137: QIAGEN NV - Key news
o Exhibit 138: QIAGEN NV - Key offerings
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 139: Thermo Fisher Scientific Inc. - Overview
o Exhibit 140: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 141: Thermo Fisher Scientific Inc. - Key news
o Exhibit 142: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 143: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 Twist Bioscience Corp.
o Exhibit 144: Twist Bioscience Corp. - Overview
o Exhibit 145: Twist Bioscience Corp. - Product / Service
o Exhibit 146: Twist Bioscience Corp. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 147: Inclusions checklist
o Exhibit 148: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 149: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 150: Research methodology
o Exhibit 151: Validation techniques employed for market sizing
o Exhibit 152: Information sources
o 13.5 List of abbreviations
o Exhibit 153: List of abbreviations
o product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Application
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Solution
Exhibits7: Executive Summary - Chart on Vendor Market Positioning
Exhibits8: Parent market
Exhibits9: Market Characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits13: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits14: Chart on US: Year-over-year growth 2022-2027 (%)
Exhibits15: Data Table on US: Year-over-year growth 2022-2027 (%)
Exhibits16: Historic Market Size - Data Table on genomics market in US 2017 - 2021 ($ million)
Exhibits17: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits18: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Solution Segment 2017 - 2021 ($ million)
Exhibits20: Five forces analysis - Comparison between 2022 and 2027
Exhibits21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits23: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits24: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits25: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits26: Chart on Market condition - Five forces 2022 and 2027
Exhibits27: Chart on Application - Market share 2022-2027 (%)
Exhibits28: Data Table on Application - Market share 2022-2027 (%)
Exhibits29: Chart on Comparison by Application
Exhibits30: Data Table on Comparison by Application
Exhibits31: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibits32: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibits33: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits34: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits35: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibits36: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibits37: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits38: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits39: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits40: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits41: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits42: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits43: Market opportunity by Application ($ million)
Exhibits44: Data Table on Market opportunity by Application ($ million)
Exhibits45: Chart on End-user - Market share 2022-2027 (%)
Exhibits46: Data Table on End-user - Market share 2022-2027 (%)
Exhibits47: Chart on Comparison by End-user
Exhibits48: Data Table on Comparison by End-user
Exhibits49: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits50: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits51: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits52: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits53: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits54: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits55: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits56: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits57: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits58: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits59: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits60: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits61: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits65: Market opportunity by End-user ($ million)
Exhibits66: Data Table on Market opportunity by End-user ($ million)
Exhibits67: Chart on Solution - Market share 2022-2027 (%)
Exhibits68: Data Table on Solution - Market share 2022-2027 (%)
Exhibits69: Chart on Comparison by Solution
Exhibits70: Data Table on Comparison by Solution
Exhibits71: Chart on Products - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Products - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Products - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Products - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Services - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Services - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Services - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Services - Year-over-year growth 2022-2027 (%)
Exhibits79: Market opportunity by Solution ($ million)
Exhibits80: Data Table on Market opportunity by Solution ($ million)
Exhibits81: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits82: Impact of drivers and challenges in 2022 and 2027
Exhibits83: Overview on Criticality of inputs and Factors of differentiation
Exhibits84: Overview on factors of disruption
Exhibits85: Impact of key risks on business
Exhibits86: Vendors covered
Exhibits87: Matrix on vendor position and classification
Exhibits88: Agilent Technologies Inc. - Overview
Exhibits89: Agilent Technologies Inc. - Business segments
Exhibits90: Agilent Technologies Inc. - Key offerings
Exhibits91: Agilent Technologies Inc. - Segment focus
Exhibits92: BGI Genomics Co. Ltd. - Overview
Exhibits93: BGI Genomics Co. Ltd. - Product / Service
Exhibits94: BGI Genomics Co. Ltd. - Key offerings
Exhibits95: Bio Rad Laboratories Inc. - Overview
Exhibits96: Bio Rad Laboratories Inc. - Business segments
Exhibits97: Bio Rad Laboratories Inc. - Key news
Exhibits98: Bio Rad Laboratories Inc. - Key offerings
Exhibits99: Bio Rad Laboratories Inc. - Segment focus
Exhibits100: Color Health Inc. - Overview
Exhibits101: Color Health Inc. - Product / Service
Exhibits102: Color Health Inc. - Key offerings
Exhibits103: Danaher Corp. - Overview
Exhibits104: Danaher Corp. - Business segments
Exhibits105: Danaher Corp. - Key news
Exhibits106: Danaher Corp. - Key offerings
Exhibits107: Danaher Corp. - Segment focus
Exhibits108: F. Hoffmann La Roche Ltd. - Overview
Exhibits109: F. Hoffmann La Roche Ltd. - Business segments
Exhibits110: F. Hoffmann La Roche Ltd. - Key news
Exhibits111: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits112: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits113: Illumina Inc. - Overview
Exhibits114: Illumina Inc. - Business segments
Exhibits115: Illumina Inc. - Key news
Exhibits116: Illumina Inc. - Key offerings
Exhibits117: Illumina Inc. - Segment focus
Exhibits118: LetsGetChecked - Overview
Exhibits119: LetsGetChecked - Product / Service
Exhibits120: LetsGetChecked - Key offerings
Exhibits121: Myriad Genetics Inc. - Overview
Exhibits122: Myriad Genetics Inc. - Product / Service
Exhibits123: Myriad Genetics Inc. - Key offerings
Exhibits124: Oxford Nanopore Technologies plc - Overview
Exhibits125: Oxford Nanopore Technologies plc - Product / Service
Exhibits126: Oxford Nanopore Technologies plc - Key offerings
Exhibits127: Pacific Biosciences of California Inc. - Overview
Exhibits128: Pacific Biosciences of California Inc. - Product / Service
Exhibits129: Pacific Biosciences of California Inc. - Key offerings
Exhibits130: PerkinElmer Inc. - Overview
Exhibits131: PerkinElmer Inc. - Business segments
Exhibits132: PerkinElmer Inc. - Key news
Exhibits133: PerkinElmer Inc. - Key offerings
Exhibits134: PerkinElmer Inc. - Segment focus
Exhibits135: QIAGEN NV - Overview
Exhibits136: QIAGEN NV - Product / Service
Exhibits137: QIAGEN NV - Key news
Exhibits138: QIAGEN NV - Key offerings
Exhibits139: Thermo Fisher Scientific Inc. - Overview
Exhibits140: Thermo Fisher Scientific Inc. - Business segments
Exhibits141: Thermo Fisher Scientific Inc. - Key news
Exhibits142: Thermo Fisher Scientific Inc. - Key offerings
Exhibits143: Thermo Fisher Scientific Inc. - Segment focus
Exhibits144: Twist Bioscience Corp. - Overview
Exhibits145: Twist Bioscience Corp. - Product / Service
Exhibits146: Twist Bioscience Corp. - Key offerings
Exhibits147: Inclusions checklist
Exhibits148: Exclusions checklist
Exhibits149: Currency conversion rates for US$
Exhibits150: Research methodology
Exhibits151: Validation techniques employed for market sizing
Exhibits152: Information sources
Exhibits153: List of abbreviations